Biofrontera AG (B8F.DE) - Stock Prices, Stock Peers & Analysis

Home
B8F.DE

Company Name	Biofrontera AG
Symbol	B8F.DE
Currency	EUR
Price	6.804
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	20,673,478
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	0.296 - 22.575
Industry	Drug Manufacturers—Specialty & Generic
Sector	Healthcare
CEO	Ms. Pilar de la Huerta Martinez
Website	https://www.biofrontera.com

An error occurred while fetching data.

About Biofrontera AG

Biofrontera AG, a biopharmaceutical company, engages in the research, development, and marketing of dermatological products. Its products include Ameluz and BF-RhodoLED lamp for the treatment of mild and moderate actinic keratoses on the face and scalp, field cancerization, and fatal squamous cell carcinoma. The company also develops RhodoLED XL for